SCHEMBL19112453

SCHEMBL19112453

CCC(CO)Nc1nc(N(C)c2ccc(F)cc2)c2ncn(C(C)C)c2n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.60
▸ CDK2 P24941 17/20 0.58
▸ CDK5 Q00535 13/20 0.58
▸ CDK5R1 Q15078 11/20 0.58
▸ CCNE1 P24864 7/20 0.58
▸ CDK9 P50750 4/20 0.58
▸ CCNT1 O60563 2/20 0.58
▸ DYRK1A Q13627 11/20 0.56
▸ CCNA2 P20248 10/20 0.56
▸ CCNA1 P78396 10/20 0.56
▸ CDK1 P06493 7/20 0.56
▸ CCNB1 P14635 5/20 0.56
▸ CDK7 P50613 4/20 0.55
▸ CSNK1D P48730 2/20 0.55
▸ CLK2 P49760 2/20 0.55
▸ CSNK1G2 P78368 2/20 0.55
▸ CLK4 Q9HAZ1 2/20 0.55
▸ CSNK1G1 Q9HCP0 2/20 0.55
▸ CCNB2 O95067 2/20 0.55
▸ CDK4 P11802 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19112171 1.00 NPSR1 (0.60) NPSR1CDK2CDK5CDK5R1CCNE1
SCHEMBL23993161 0.91 CDK1 (0.65) NPSR1CDK2CDK5CDK5R1CCNE1
SCHEMBL19112178 0.90 NPSR1 (0.67) NPSR1CDK2CDK5CDK5R1CCNE1
SCHEMBL15387124 0.90 NPSR1 (0.67) NPSR1CDK2CDK5CDK5R1CCNE1
SCHEMBL30356263 0.90 NPSR1 (0.67) NPSR1CDK2CDK5CDK5R1CCNE1
SCHEMBL19112192 0.90 NPSR1 (0.67) NPSR1CDK2CDK5CDK5R1CCNE1
Hydrochloric Acid SCHEMBL30268945 0.89 NPSR1 (0.66) NPSR1CDK2CDK5CDK5R1CCNE1
Hydrochloric Acid SCHEMBL23927317 0.89 NPSR1 (0.66) NPSR1CDK2CDK5CDK5R1CCNE1
Hydrochloric Acid SCHEMBL23927315 0.89 NPSR1 (0.66) NPSR1CDK2CDK5CDK5R1CCNE1
SCHEMBL23992718 0.89 NPSR1 (0.59) NPSR1CDK2CDK5CDK5R1CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3901154-A1 PURINE DERIVATIVES AS DRUGS FOR THE TREATMENT OF NEONATAL HYPOXIA-ISCHEMIA BRAIN INJURY AND RELATED DISEASES Commissariat à l'énergie atomique et aux énergies alternatives (FR) 2021-10-27 — — EP disclosed
EP-2664619-B1 Purine derivatives as tools for screening anti-Alzheimer compounds MANROS THERAPEUTICS (FR) 2017-07-12 — — EP disclosed
Send feedback